VKTX logo

VKTX
Viking Therapeutics Inc

37,584
Mkt Cap
$4.24B
Volume
1.08M
52W High
$49.67
52W Low
$18.92
PE Ratio
-17.72
VKTX Fundamentals
Price
$37.42
Prev Close
$37.53
Open
$36.96
50D MA
$35.30
Beta
1.41
Avg. Volume
3.86M
EPS (Annual)
-$1.01
P/B
5.92
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Can NVO Defend Its Obesity Lead as GLP-1 Competition Intensifies?
Novo Nordisk faces slowing semaglutide momentum as new obesity contenders, including GPCR's aleniglipron, push the competitive landscape forward.
Zacks·1d ago
News Placeholder
More News
News Placeholder
PFE Buys Oral GLP-1 Drug From China Biotech to Boost Obesity Presence
Pfizer boosts its obesity ambitions by licensing YP05002, an oral GLP-1 drug now in phase I, aiming to rebuild momentum in weight-loss treatments.
Zacks·1d ago
News Placeholder
GPCR Stock Soars 102% on Strong Phase II Obesity Data for Aleniglipron
Structure Therapeutics jumps after phase II data show aleniglipron delivering strong, durable weight-loss results across multiple studies.
Zacks·2d ago
News Placeholder
GPCR Stock Soars 102% on Strong Phase II Obesity Data for Aleniglipron
Structure Therapeutics jumps after phase II data show aleniglipron delivering strong, durable weight-loss results across multiple studies.
Zacks·2d ago
News Placeholder
Looking At Viking Therapeutics's Recent Unusual Options Activity
read more...
Benzinga·3d ago
News Placeholder
Franklin Resources Inc. Has $703,000 Stock Holdings in Viking Therapeutics, Inc. $VKTX
Franklin Resources Inc. reduced its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 85.7% in the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·3d ago
News Placeholder
Franklin Resources Inc. Has $703,000 Stock Holdings in Viking Therapeutics, Inc. $VKTX
Franklin Resources Inc. reduced its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 85.7% in the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·3d ago
News Placeholder
Viking Therapeutics (NASDAQ:VKTX) Shares Up 9.4% - Here's Why
Viking Therapeutics (NASDAQ:VKTX) Trading 9.4% Higher - Time to Buy...
MarketBeat·6d ago
News Placeholder
Schroder Investment Management Group Buys 150,470 Shares of Viking Therapeutics, Inc. $VKTX
Schroder Investment Management Group increased its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 89.1% in the second quarter, according to the company in its most recent...
MarketBeat·6d ago
News Placeholder
Schroder Investment Management Group Buys 150,470 Shares of Viking Therapeutics, Inc. $VKTX
Schroder Investment Management Group increased its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 89.1% in the second quarter, according to the company in its most recent...
MarketBeat·6d ago

Latest VKTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.